Cure My Disease

Don't miss your cure!

 Log in / Sign up

Stem cell shot aims to save limbs in rare artery disease

NCT ID NCT05854615

Recruiting now Disease control Sponsor: Cell Biopeutics Resources Sdn Bhd Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study is testing whether injections of Stempeucel, a stem cell product made from donor bone marrow, can help people with critical limb ischemia caused by Buerger's disease. The goal is to see if it reduces pain, heals ulcers, improves blood flow, and prevents amputation. Only 3 participants will be enrolled, and they will be followed for one year to check safety and effectiveness.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Stempeucel (stem cells from donor bone marrow)
What this could lead to
If it works, this could point toward a treatment that reduces pain, heals ulcers, and lowers amputation risk for people with Buerger's disease.
What could go wrong
This is a very small feasibility study with only 3 participants, so results may not apply broadly. Stem cell treatments can have side effects like infection or immune reactions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BUERGER'S DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Chronic Limb-Threatening Ischemia limb ischemia thromboangiitis obliterans

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BUERGER'S DISEASE CRITICAL LIMB ISCHEMIA

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • Hospital Canselor Tunku Mukhriz

    RECRUITING

    Kuala Lumpur, 56000, Malaysia

More trials for these conditions

Other studies related to the condition(s) this trial covers.